Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

ClinicalTrials.gov ID: NCT04566445

Public ClinicalTrials.gov record NCT04566445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

HORIZON: A Phase II, Open-label, Outcomes-assessor Masked, Multicentre, Randomised, Controlled Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical study was to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).

Study identification

NCT ID
NCT04566445
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gyroscope Therapeutics Limited
Industry
Enrollment
255 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2020 (Actual)
Primary completion
Jun 10, 2024 (Actual)
Completion
Jun 10, 2024 (Actual)
Last update posted
Jan 28, 2026

2020 – 2024

United States locations

U.S. sites
45
U.S. states
23
U.S. cities
44
Facility City State ZIP Site status
Retinal Research Institute (retina consultants of AZ) Phoenix Arizona 85053 —
Retina Vitreous Associates Medical Group Beverly Hills California 90211 —
Retina Consultants of Orange County Fullerton California 92835 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Byers Eye Institute at Stanford Palo Alto California 94303 —
Retina Consultants of San Diego Poway California 92064 —
University of California (UC) Davis Medical Group Eye Center Sacramento California 95817 —
Southwest Retina Research Center Durango Colorado 81303 —
Rand Eye Institute Deerfield Beach Florida 33064 —
VitreoRetinal Associates, P.A. Gainesville Florida 32607 —
Bascom Palmer Eye Institute Miami Florida 33136 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33711 —
Southeast Retina Center Augusta Georgia 30909 —
Georgia Retina PC Marietta Georgia 30060 —
Illinois Retina Associates Chicago Illinois 60657 —
University Retina Macula Associates PC Lemont Illinois 60452 —
Midwest Eye Institute Northside Indianapolis Indiana 46290 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates, LLC Shawnee Mission Kansas 66204 —
The Retina Care Center Baltimore Maryland 21209 —
Ophthalamic Consultants of Boston (OCB) Boston Massachusetts 02114 —
Retina Associates of Michigan Grand Blanc Michigan 48439 —
Associated Retinal Consultants PC Royal Oak Michigan 48073 —
Sierra Eye Associates Reno Nevada 89502 —
Columbia University Medical Center New York New York 10032 —
Retina Associates of Western New York Rochester New York 14620 —
Duke Eye Center Durham North Carolina 27705 —
Cincinnati Eye Institute Cincinnati Ohio 45242 —
Cleveland Clinic Cleveland Ohio 44195 —
Oregon Retina Eugene Oregon 97401 —
Casey Eye Institute - OHSU Portland Oregon 97239 —
Erie Retinal Surgery ,INC Erie Pennsylvania 16507 —
Mid Atlantic Retina - Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Charles Retina Institute Germantown Tennessee 38138 —
Southeastern Retina Associates, PC Knoxville Tennessee 37922 —
Austin Research Center for Retina, PLLC Austin Texas 78705 —
Retina Consultants of Houston-TMC Bellaire Texas 77401 —
Retina Foundation of the Southwest Dallas Texas 75231 —
Texas Retina Associates (Dallas) Dallas Texas 75231 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
Retina Consultants of Houston The Woodlands Texas 77384 —
Rocky Mountain Retina Consultants Salt Lake City Utah 84107 —
Department of Ophthalmology UW Medicine Seattle Washington 98104-2499 —
Retina Center Northwest Silverdale Washington 98383 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04566445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04566445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →